Analytical demand of CRISPR gene therapies Gene Editing?CRISPR-Cas9 gene editing offers substantial improvements over previous gene editing technologies in terms of ease of use, speed, efficacy, and cost. Not surprisingly, CRISPR-Cas9 editing … more ➔
Medical cold chain for gene and cell therapies The medical cold chain is the network of refrigerators, freezers, and transport solutions tasked to always keep samples and specimens at their intended temperatures. When it comes to cell and gene research … more ➔
Success together with CDMOsWhen the time comes for a biopharma company to outsource its production, or to get support for the development of a new project, the pool of available CDMOs is quite deep. Everyone knows the big players, … more ➔
Regulatory & methodological trends in the labWhat started in 2013 as an attempt – to offer experts in analytical and microbiological quality control, contract laboratories, representatives from authorities and service providers an industry event … more ➔
Universitätsklinikum Heidelberg Automation is key to saving lives Cell and Gene Therapy Processing?Personalised tumour treatments are expensive. This particularly applies to individual cancer therapies based on gene-modified T cells. Currently, they are produced manually … more ➔
Advancing cancer immunotherapySingle cell multiomics has the capacity to address key challenges to developing cell and gene therapies, specifically CAR T-cell therapies. Hear how leading cancer immunotherapy researchers are using … more ➔
BioSpain 2021, showcasing Spanish biotech leap forward The largest biotech event organised by a national bioindustry association (AseBio) in Europe and one of the biggest in the world will take place from 27 September to 1 October. To be held in Pamplona-Iruña, … more ➔
Managing risks and finding opportunities through logisticsBy applying the expertise, best practice, and emerging technologies of the logistics industry, biotech not only prevents the missteps that can destroy its products, it can also capitalise on opportunities … more ➔
Medical Cannabis in Europe – the next frontierThe cannabis industry has established its first footholds in Europe over the past six years – but what comes next? European Biotechnology invited US-German American consultant, entrepreneur and author … more ➔
Tough times for cancer cell therapiesSo far, no gene and cell therapies have been approved to treat solid tumours. European Biotechnology spoke with Karen Miller, SVP Pipeline Research at Adaptimmune plc, about promising candidates, and … more ➔
Universitätsklinikum Heidelberg
